LifeTech Scientific Corporation (01302.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.38

From 52W high−42.86%

Volume18.54M

Market capHKD 5.77B

P/E (TTM)88.2x

P/S (TTM)3.8x

Div yield—

Key dataSep 18, 2026

Open

HKD 1.38

From 52W high

−42.86%

Volume

18.54M

Market cap

HKD 5.77B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.2x

P/E (TTM)

88.2x

RSI (14)

40.8

MomentumView details →

1D Return

−4.00%

YTD Return

−15.38%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

88.2x

EV/EBITDA

13.2x

EV/Sales

2.8x

P/S (TTM)

3.8x

P/B (TTM)

1.5x

ProfitabilityView details →

Gross Margin

76.29%

Net Margin

4.54%

EBITDA Margin

21.49%

ROE (TTM)

1.76%

ROA (TTM)

1.23%

Asset Turnover

0.26x

GrowthView details →

Revenue YoY

−3.16%

EPS YoY

−22.89%

FCF YoY

−16.07%

Revenue CAGR 3Y

+7.67%

EPS CAGR 3Y

−24.61%

EBITDA YoY

+105.88%

MomentumView details →

1D Return

−4.00%

YTD Return

−15.38%

1Y Return

−29.41%

RSI (14)

40.8

vs 50D SMA

−5.79%

vs 200D SMA

−19.95%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

2.45x

Quick Ratio

1.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.01

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.61B

Net Income (TTM)

130.31M

Op. CF (TTM)

1.14B

Next earningsMar 31, 2027 →

Latest newsMore news →

Lifetech Scientific announced the termination of its proposed acquisition of Huayi Medical equity and the related convertible bond issuance, after negotiations failed to reach an agreement.62d ago

Similar companies

浩欧博688656.SH AK Medical Holdings Limited01789.HK 春立医疗688236.SH Zylox-Tonbridge Medical Technology Co., Ltd.02190.HK 三友医疗688085.SH XD基蛋生603387.SH Find similar companies →

Latest newsMore news →

Lifetech Scientific announced the termination of its proposed acquisition of Huayi Medical equity and the related convertible bond issuance, after negotiations failed to reach an agreement.62d ago